Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantDKSH SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
CAPSULE
ORAL
Medical Information
L01EX22
selpercatinib
Manufacturer Information
DKSH SINGAPORE PTE. LTD.
Lilly del Caribe, Inc.
Lilly, S.A. (Primary and Secondary Packager)
Active Ingredients
Documents
Package Inserts
Tanstrive Hard Capsule PI.pdf
Approved: April 24, 2024